← ABBOTT LABORATORIES ABT
Market Price
$111.26
Market Cap
$193.81B
P/E Ratio
29.91
Revenue (FY 2025)
↑5.7% YoY
$44.33B
3-Yr CAGR: 0.5%
Net Income
↓-51.3% YoY
$6.52B
Net Margin: 14.7%
Free Cash Flow
↑16.4% YoY
$7.39B
FCF Yield: 3.82%
EPS (Diluted)
↓-51.3% YoY
$3.72
Basic: $3.73
Return on Equity
Efficiency
12.5%
ROA: 7.5%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (ABT)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $20,853.0M | — | $11,829.0M | $1,400.0M | — | $0.94 | — | $3,203.0M | $2,082.0M | — |
| FY 2017 | $27,390.0M | +31.3% | $15,053.0M | $477.0M | -65.9% | $0.27 | -71.3% | $5,570.0M | $4,435.0M | +113.0% |
| FY 2018 | $30,578.0M | +11.6% | $17,872.0M | $2,368.0M | +396.4% | $1.33 | +392.6% | $6,300.0M | $4,906.0M | +10.6% |
| FY 2019 | $31,904.0M | +4.3% | $18,673.0M | $3,687.0M | +55.7% | $2.06 | +54.9% | $6,136.0M | $4,498.0M | -8.3% |
| FY 2020 | $34,608.0M | +8.5% | $19,605.0M | $4,495.0M | +21.9% | $2.50 | +21.4% | $7,901.0M | $5,724.0M | +27.3% |
| FY 2021 | $43,075.0M | +24.5% | $24,538.0M | $7,071.0M | +57.3% | $3.94 | +57.6% | $10,533.0M | $8,648.0M | +51.1% |
| FY 2022 | $43,653.0M | +1.3% | $24,511.0M | $6,933.0M | -2.0% | $3.91 | -0.8% | $9,581.0M | $7,804.0M | -9.8% |
| FY 2023 | $40,109.0M | -8.1% | $22,134.0M | $5,723.0M | -17.5% | $3.26 | -16.6% | $7,261.0M | $5,059.0M | -35.2% |
| FY 2024 | $41,950.0M | +4.6% | $23,244.0M | $13,402.0M | +134.2% | $7.64 | +134.4% | $8,558.0M | $6,351.0M | +25.5% |
| FY 2025 | $44,328.0M | +5.7% | $25,009.0M | $6,524.0M | -51.3% | $3.72 | -51.3% | $9,566.0M | $7,395.0M | +16.4% |
Valuation
Market Price
$111.26
Market Cap
$193.81B
Enterprise Value
$198.22B
P/E Ratio
29.91
P/B Ratio
3.72
FCF Yield
3.82%
Dividend Yield
2.16%
Shares Outstanding
Profitability & Margins
Gross Margin
56.42%
Operating Margin
18.17%
Net Margin
14.72%
Return on Equity (ROE)
12.51%
Return on Assets (ROA)
7.52%
Asset Turnover
0.51x
Revenue 3-Yr CAGR
0.51%
Financial Health & Liquidity
Current Ratio
1.58
Cash Ratio
0.52
Debt / Equity
0.248
Debt / Assets
0.149
Cash & Equivalents
$8.52B
Total Debt
$12.93B
Book Value / Share
$29.93
Cash Flow Efficiency
Operating Cash Flow
$9.57B
Capital Expenditures (CapEx)
$2.17B
Free Cash Flow
$7.39B
OCF / Revenue
21.58%
FCF / Revenue
16.68%
FCF 3-Yr CAGR
-1.78%
Per Share Metrics
EPS (Diluted)
$3.72
EPS (Basic)
$3.73
Dividends / Share
$2.40
Book Value / Share
$29.93
EPS YoY Growth
-51.31%
Balance Sheet (FY 2025)
Total Assets
$86.71B
Total Liabilities
$86.71B
Stockholders' Equity
$52.13B
Current Assets
$26.00B
Current Liabilities
$16.50B